US Bancorp’s Vor Biopharma VOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$630 Buy
+33
New +$704 ﹤0.01% 4107
2022
Q1
– Sell
-81
Closed -$19K – 4210
2021
Q4
$19K Buy
81
+75
+1,250% +$21.6K ﹤0.01% 3147
2021
Q3
$2K Buy
+6
New +$1.78K ﹤0.01% 3929

Other funds holding VOR

US Bancorp's VOR Position: Q3 2026 in Review

US Bancorp opened a new position in Vor Biopharma (VOR) in Q3 2026: 33 shares worth $630. The stake represents ﹤0.01% of the portfolio and ranks #4107 among its holdings. This is a return to the name: US Bancorp previously reported a position in VOR as recently as Q4 2021.

US Bancorp first reported a position in VOR in Q3 2021 and has held it in 3 quarters since. The position peaked at $19K in Q4 2021. 76 funds tracked by Wall St. Rank hold VOR as of Q3 2026.

  • US Bancorp held 33 shares of Vor Biopharma worth $630 as of Q3 2026.
  • Vor Biopharma was a new US Bancorp position in Q3 2026.
  • Vor Biopharma made up ﹤0.01% of US Bancorp's portfolio in Q3 2026, its #4107 holding.
  • US Bancorp first reported a position in Vor Biopharma in Q3 2021 and has held it in 3 quarters since.
  • US Bancorp's Vor Biopharma position peaked at $19K in Q4 2021.
  • 76 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2026.

Based on US Bancorp's 13F filing for Q3 2026, filed 5 Nov 2026.